Protective effect of Euterpe oleracea Mart (açaí) extract on programmed changes in the adult rat offspring caused by maternal protein restriction during pregnancy

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 9, 2014, Pages 1328-1338

  De Bem, Graziele Freitas ^a   Da Costa, Cristiane Aguiar ^a   De Oliveira, Paola Raquel Braz ^a   Cordeiro, Viviane Silva Cristino ^a   Santos, Izabelle Barcellos ^a   De Carvalho, Lenize Costa Reis Marins ^a   Souza, Marcelo Augusto Vieira ^a   Ognibene, Dayane Texeira ^a   Daleprane, Julio Beltrame ^b   Sousa, Pergentino José Cunha ^a   Resende, Angela Castro ^a   De Moura, Roberto Soares ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Euterpe oleracea Mart.; hypertension; low protein; oxidative stress; renal failure

Indexed keywords

ACETYLCHOLINE; CARBONYL DERIVATIVE; CARDIOVASCULAR AGENT; CREATININE; EUTERPE OLERACEA EXTRACT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRITE; PLANT EXTRACT; SODIUM; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UREA; URINARY TRACT AGENT; ANTIOXIDANT; PROTEIN INTAKE; VASODILATOR AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARECACEAE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PROTECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EUTERPE OLERACEA; FEMALE; GLOMERULOPATHY; GLUTATHIONE PEROXIDASE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY SIZE; KIDNEY STRUCTURE; MALE; MALONALDEHYDE BLOOD LEVEL; MATERNAL NUTRITION; NITRITE BLOOD LEVEL; NONHUMAN; PLANT SEED; PREGNANCY; PROGENY; PROTEIN RESTRICTION; RAT; RENAL PROTECTION; SERUM; SODIUM URINE LEVEL; SUPEROXIDE DISMUTASE BLOOD LEVEL; UREA BLOOD LEVEL; UROGENITAL SYSTEM PARAMETERS; VASODILATATION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG EFFECTS; EUTERPE; FETUS DEVELOPMENT; KIDNEY; KIDNEY DISEASES; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYTOTHERAPY; PRENATAL EXPOSURE; PROTEIN INTAKE; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; DIET, PROTEIN-RESTRICTED; DIETARY PROTEINS; EUTERPE; FEMALE; FETAL DEVELOPMENT; HYPERTENSION; KIDNEY; KIDNEY DISEASES; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS, WISTAR; SEEDS; VASODILATION; VASODILATOR AGENTS;

EID: 84906326886     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12258     Document Type: Article

References (43)

1. Barker DJ,. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31: 1235-1239.
2. Frasch MG, et al. Fetal body weight and the development of the control of the cardiovascular system in fetal sheep. J Physiol 2007; 579: 893-907.
3. Al-Gubory KH, et al. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol 2010; 10: 1634-1650.
4. Mesquita FF, et al. Expression of renin-angiotensin system signaling compounds in maternal protein-restricted rats: effect on renal sodium excretion and blood pressure. Nephrol Dial Transplant 2010; 25: 380-388.
5. Sathishkumar K, et al. Protein restriction during pregnancy induces hypertension and impairs endothelium-dependent vascular function in adult female offspring. J Vasc Res 2009; 3: 229-239.
6. Langley-Evans SC, et al. Maternal protein restriction and fetal growth: lack of evidence of a role for homocysteine in fetal programming. Br J Nutr 2006; 96: 578-586.
7. Pires KM, et al. Early renal structure alteration in rat offspring from dams fed low protein diet. Life Sci 2006; 22: 2128-2134.
8. Sangronis E, Sanabria N,. Impact of solar dehydration on composition and antioxidant properties of açai (Euterpe oleracea Mart.). Arch Latinoam Nutr 2011; 61: 74-80.
9. Matheus ME, et al. Inhibitory effects of Euterpe oleracea Mart. on nitric oxide production and iNOS expression. J Ethnopharmacol 2006; 107: 291-296.
10. Santos-Silva EN, Scudeller VV,. Biotupé-Meio Físico, Diversidade Biolõgica e Sociocultural do Bairo Rio Negro, Amazônia Central, Vol. 2. Manaus-M: Editora UEA, 2009.
11. Curin Y, Andriantsitohaina R,. Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol Rep 2005; 57: 97-107.
12. Mertens-Talcott SU, et al. Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich açaí juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers. J Agric Food Chem 2008; 56: 7796-7802.
13. Schauss AG, et al. Phytochemical and nutrient composition of the freeze-dried amazon palm berry, Euterpe oleracea Mart. (açaí). J Agric Food Chem 2006; 54: 8598-8603.
14. Rocha APM, et al. Endothelium-dependent vasodilator effect of Euterpe oleracea Mart. (açaí) extracts in mesenteric vascular bed of the rat. Vasc Pharmacol 2007; 46: 97-104.
15. Rocha APM, et al. Antihypertensive effects and antioxidant action of a hydro-alcoholic extract obtained from fruits of Euterpe oleracea Mart. (açaí). J Pharmacol Toxicol 2008; 3: 435-448.
16. Costa CA, et al. Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress. Naunyn Schmiedebergs Arch Pharmacol 2012; 385: 1199-1209.
17. Singleton VL, Rossi JA,. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic 1965; 16: 144-158.
18. AOAC-990.03. Protein (crude) in animal feed, combustion method. In:, Windham WR, ed. Official Methods of Analysis of the Association of Official Analytical Chemists, 16th edn. Arlington, VA: AOAC, 1995: 18-19.
19. Moura RS, et al. Effects of Euterpe oleracea Mart. (açaí) extract in acute lung inflammation induced by cigarette smoke in the mouse. Phytomedicine 2012; 19: 262-269.
20. Reeves PG, et al. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123: 1939-1951.
21. Draper HH, et al. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 1993; 15: 353-363.
22. Levine RL, et al. Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 1990; 186: 464-478.
23. Green LC, et al. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
24. Bannister JV, Calabrese L,. Assays for superoxide dismutase. Methods Biochem Anal 1982; 32: 131-138.
25. Aebi H,. Catalase in vitro. Meth Enzymol 1984; 105: 121-126.
26. Flohé L, Günzler WA,. Assays of glutathione peroxidase. Methods Enzymol 1984; 105: 114-121.
27. Bertram JF, et al. Total numbers of glomeruli and individual glomerular cell types in the normal rat kidney. Cell Tissue Res 1992; 270: 37-45.
28. Barker DJ, Osmond C,. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986; 1: 1077-1081.
29. Brawley L, et al. Mechanisms underlying the programming of small artery dysfunction: review of the model using low protein diet in pregnancy in the rat. Arch Physiol Biochem 2003; 111: 23-35.
30. Sherman RC, Langley-Evans SC,. Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension programmed by intrauterine exposure to a maternal low-protein diet in the rat. Clin Sci 1998; 94: 373-381.
31. Rodford JL, et al. Endothelial dysfunction and reduced antioxidant protection in an animal model of the developmental origins of cardiovascular disease. J Physiol 2008; 586: 4709-4720.
32. Torrens C, et al. Maternal undernutrition leads to endothelial dysfunction in adult male rat offspring independent of postnatal diet. Br J Nutr 2009; 101: 27-33.
33. Cambonie G, et al. Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet. Am J Physiol Regul Integr Comp Physiol 2007; 292: 1236-1245.
34. Koumentaki A, et al. Low-protein diet impairs vascular relaxation in virgin and pregnant rats. Clin Sci 2002; 102: 553-560.
35. Huang LT, et al. Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming. Int J Mol Sci 2012; 13: 14606-14622.
36. Tain YL, et al. Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway. Nitric Oxide 2010; 23: 34-41.
37. Kulandavelu S, et al. Endothelial nitric oxide synthase deficiency reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant mice. Hypertension 2012; 60: 231-238.
38. Andriantsitohaina R, et al. Molecular mechanisms of the cardiovascular protective effects of polyphenols. Br J Nut 2012; 108: 1532-1549.
39. Luo ZC, et al. Tracing the origins of 'fetal origins' of adult diseases: Programming by oxidative stress? Med Hypotheses 2006; 66: 38-44.
40. Fetoui H, et al. Protein restriction in pregnant- and lactating rats-induced oxidative stress and hypohomocysteinaemia in their offspring. J Anim Physiol Anim Nutr 2009; 93: 263-270.
41. Tarry-Adkins JL, et al. Protein restriction in lactation confers associated with increased antioxidant expression nephroprotective effects in the male rat and is associated with increased antioxidant expression. Am J Physiol Regul Integr Comp Physiol 2007; 293: 1259-1266.
42. Almeida JR, Mandarim-de-Lacerda CA,. Maternal gestational protein-calorie restriction decreases the number of glomeruli and causes glomerular hypertrophy in adult hypertensive rats. Am J Obstet Gynecol 2005; 192: 945-951.
43. Sahajpal V, Ashton N,. Increased glomerular angiotensin II binding in rats exposed to a maternal low protein diet in utero. J Physiol 2005; 563: 193-1001.